← All trials
NCT05980637
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2023
- Primary completion
- Feb 28, 2025
- Completion date
- Aug 31, 2025
- First posted
- Aug 8, 2023
- Last posted
- Aug 8, 2023
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chinese University of Hong KongLead sponsor
- Chinese University of Hong KongReponsible party - principal investigator
- Hong Kong Institute of Integrative MedicineOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.